Aberdeen Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$22.1M Buy
268,608
+32,576
+14% +$2.66M 0.07% 235
2017
Q1
$19.9M Buy
236,032
+12,100
+5% +$969K 0.07% 232
2016
Q4
$16.5M Sell
223,932
-28,456
-11% -$2.12M 0.06% 251
2016
Q3
$20.3M Sell
252,388
-2,863
-1% -$229K 0.07% 223
2016
Q2
$20.1M Sell
255,251
-14,125
-5% -$1.06M 0.07% 206
2016
Q1
$19.4M Sell
269,376
-28,434
-10% -$2.15M 0.07% 194
2015
Q4
$22.9M Buy
297,810
+81,853
+38% +$6.79M 0.08% 160
2015
Q3
$18.1M Sell
215,957
-8,537
-4% -$721K 0.06% 172
2015
Q2
$18.7M Sell
224,494
-7,369
-3% -$561K 0.05% 185
2015
Q1
$16.8M Sell
231,863
-250,403
-52% -$17.8M 0.05% 200
2014
Q4
$33.3M Sell
482,266
-114,321
-19% -$7.72M 0.08% 131
2014
Q3
$38.7M Sell
596,587
-107,797
-15% -$6.82M 0.09% 137
2014
Q2
$43.8M Buy
704,384
+600,267
+577% +$35.8M 0.09% 135
2014
Q1
$6.13M Sell
104,117
-400
-0.4% -$22.3K 0.02% 164
2013
Q4
$5.29M Hold
104,517
0.01% 179
2013
Q3
$5.26M Sell
104,517
-11,260
-10% -$589K 0.01% 170
2013
Q2
$5.69M Buy
+115,777
New +$6.3M 0.02% 157

Other funds holding LLY

Aberdeen Asset Management's LLY Position: Q2 2017 in Review

Aberdeen Asset Management increased its Eli Lilly (LLY) stake by 14% in Q2 2017, buying an estimated $2.66M and bringing the position to 268,608 shares worth $22.1M. The position accounts for 0.07% of the portfolio, ranked #235.

Aberdeen Asset Management first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $43.8M in Q2 2014. 1,247 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Aberdeen Asset Management held 268,608 shares of Eli Lilly worth $22.1M as of Q2 2017.
  • Aberdeen Asset Management bought 32,576 Eli Lilly shares in Q2 2017, an estimated $2.66M.
  • Eli Lilly made up 0.07% of Aberdeen Asset Management's portfolio in Q2 2017, its #235 holding.
  • Aberdeen Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
  • Aberdeen Asset Management's Eli Lilly position peaked at $43.8M in Q2 2014.
  • 1,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.